Publications by authors named "John Coombs"

Claim this Profile
P
Pd-Catalyzed Chemoselective O‑Benzylation of Ambident 2‑Quinolinone Nucleophiles.
Melissa Cadena, Roberto Silva Villatoro, Jyoti Shah Gupta, Cody Phillips, Jonathan B Allen, John R Coombs

ACS Catal· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical Perfluoroalkylation of Arenes via Carbanion Intermediates.
Lucas W Hernandez, William P Gallagher, Carlos A Guerrero, Francisco Gonzalez-Bobes, John R Coombs

J Org Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Annulating Reagents Enabling the One-Step and Highly Stereoselective Synthesis of Cyclopentyl and Cyclohexyl Cores.
Jade McDaniel, Christopher A Farley, Antonio Ramirez, Bhupinder Sandhu, Amy Sarjeant, John R Coombs

Org Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palladium(0)-Catalyzed Directed syn-1,2-Carboboration and -Silylation: Alkene Scope, Applications in Dearomatization, and Stereocontrol by a Chiral Auxiliary.
Zhen Liu, Jiahao Chen, Hou-Xiang Lu, Xiaohan Li, Yang Gao, John R Coombs

Angew Chem Int Ed Engl· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Step Diastereoselective Pyrrolidine Synthesis Using a Sulfinamide Annulating Reagent.
Qing Shi, Nathaniel S Greenwood, Mariah C Meehan, Hyunsoo Park, Michael Galella, John R Coombs

Org Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective Synthesis of Nonracemic Geminal Silylboronates by Pt-Catalyzed Hydrosilylation.
Adam A Szymaniak, Chenlong Zhang, John R Coombs, James P Morken

ACS Catal· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Robustness: In Situ Generation of a Pd(0) Catalyst for the Cyanation of Aryl Bromides.
John R Coombs, Kenneth J Fraunhoffer, Eric M Simmons, Jason M Stevens, Steven R Wisniewski

J Org Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic Enantioselective Functionalization of Unactivated Terminal Alkenes.
John R Coombs, James P Morken

Angew Chem Int Ed Engl· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of vinyl boronates from aldehydes by a practical boron-Wittig reaction.
John R Coombs, Liang Zhang, James P Morken

Org Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantiomerically enriched tris(boronates): readily accessible conjunctive reagents for asymmetric synthesis.
John R Coombs, Liang Zhang, James P Morken

J Am Chem Soc· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective carbocycle formation through intramolecular Pd-catalyzed allyl-aryl cross-coupling.
Christopher H Schuster, John R Coombs, Zachary A Kasun, James P Morken

Org Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.
François Guilhot, John Coombs, Tomasz Szczudlo, Oleg Zernovak, Marc Paolantonio

Patient· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scope and mechanism of the Pt-catalyzed enantioselective diboration of monosubstituted alkenes.
John R Coombs, Fredrik Haeffner, Laura T Kliman, James P Morken

J Am Chem Soc· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
Myrlene Sanon, Douglas C A Taylor, Anju Parthan, John Coombs, Marc Paolantonio

J Med Econ· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of different adjuvant therapies for 9 resectable cancer types.
Morgan Kruse, Anju Parthan, John Coombs, Medha Sasane, Douglas Taylor

Postgrad Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences and perspectives on the GIST patient journey.
Nancy Macdonald, Ari Shapiro, Christina Bender, Marc Paolantonio, John Coombs

Patient Prefer Adherence· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
Adam Gater, Louise Heron, Linda Abetz-Webb, John Coombs, Jeff Simmons

Leuk Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility values for chronic myelogenous leukemia chronic phase health states from the general public in the United Kingdom.
Julian F Guest, Neepa Naik, Erikas Sladkevicius, John Coombs, Elizabeth J Gray

Leuk Lymphoma· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST).
A Brett Hauber, Juan Marcos Gonzalez, John Coombs, Andres Sirulnik, David Palacios

Patient Prefer Adherence· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, survival, and costs of localized gastrointestinal stromal tumors.
Jaime L Rubin, Myrlene Sanon, Douglas Ca Taylor, John Coombs, Vamsi Bollu

Int J Gen Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budgetary impact of treatment with adjuvant imatinib for 1 year following surgical resection of Kit-positive localized gastrointestinal stromal tumors.
Jaime L Rubin, Douglas C A Taylor, Myrlene Sanon, John H Coombs, Vamsi K Bollu

J Manag Care Pharm· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.
Eric Q Wu, Scott Johnson, Nicolas Beaulieu, Mateo Arana, Vamsi Bollu, John Coombs

Curr Med Res Opin· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.
Joel M Kremer, Bradley J Bloom, Ferdinand C Breedveld, John H Coombs, Mark P Fletcher

Arthritis Rheum· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey correlations: proficiency and adequacy of nutrition training of medical students.
Tanis V Mihalynuk, John B Coombs, Michael E Rosenfeld, Craig S Scott, Robert H Knopp

J Am Coll Nutr· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary development of a responder index for chronic low back pain.
Lee S Simon, Christopher Evans, Nathaniel Katz, Claire Bombardier, Christine West, John H Coombs

J Rheumatol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis